96-32284. Issuer Delisting; Notice of Application To Withdraw From Listing and Registration; (Urohealth Systems, Inc., Common Stock, $.001 Par Value; Stock Purchase Rights; Warrants To Purchase Common Stock)

[Federal Register Volume 61, Number 246 (Friday, December 20, 1996)]
[Notices]
[Page 67365]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-32284]



[[Page 67365]]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION
[File No. 1-11150]


Issuer Delisting; Notice of Application To Withdraw From Listing 
and Registration; (Urohealth Systems, Inc., Common Stock, $.001 Par 
Value; Stock Purchase Rights; Warrants To Purchase Common Stock)

December 16, 1996.
    Urohealth Systems, Inc. (``Company'') has filed an application with 
the Securities and Exchange Commission (``Commission''), pursuant to 
Section 12(d) of the Securities Exchange Act of 1934 (``Act'') and Rule 
12d2-2(d) promulgated thereunder, to withdraw the above specified 
securities (``Securities'') from listing and registration on the 
American Stock Exchange, Inc. (``Amex'').
    The reasons alleged in the application for withdrawing the 
Securities from listing and registration include the following:
    According to the Company, its Board of Directors unanimously 
approved resolutions on October 1, 1996 to withdraw the Securities from 
listing on the Amex and instead, to list the Securities on the National 
Association of Securities Dealers Automated Quotations National Market 
System (``Nasdaq/NMS'').
    The decision of the Board followed a through study of the matter 
and was based upon the belief that listing the Securities on the 
Nasdaq/NMS will be more beneficial to the Company's stockholders than 
the present listing on the Amex because:
    The Board anticipates additional market coverage by institutional 
investors and greater market support among analysts and an increase in 
liquidity of the Company's Common Stock and Warrants will result from 
the transfer to the Nasdaq/NMS.
    Any interested person may, on or before January 8, 1997 submit by 
letter to the Secretary of the Securities and Exchange Commission, 450 
Fifth Street, N.W., Washington, D.C. 20549, facts bearing upon whether 
the application has been made in accordance with the rules of the 
exchanges and what terms, if any, should be imposed by the Commission 
for the protection of investors. The Commission, based on the 
information submitted to it, will issue an order granting the 
application after the date mentioned above, unless the Commission 
determines to order a hearing on the matter.

    For the Commission, by the Division of Market Regulation, 
pursuant to delegated authority.
Jonathan G. Katz,
Secretary.
[FR Doc. 96-32284 Filed 12-19-96; 8:45 am]
BILLING CODE 8010-01-M